Open-label, multicenter, single-arm phase II study (DeCOG-Trial) to further evaluate the efficacy and safety of ipilimumab in patients with cutaneous melanoma and rare subgroups.

被引：1

作者：

Zimmer, Lisa

Eigentler, Thomas K.

Vaubel, Julia-Marianne

Mohr, Peter

Jradi, Zeinab

Kiecker, Felix

Utikal, Jochen

Berking, Carola

Kaempgen, Eckhart

Hauschild, Axel

Dippel, Edgar

Rompel, Rainer

Fluck, Michael

Stadler, Rudolf

Herbst, Rudolf

Terheyden, Patrick

Garbe, Claus

Loquai, Carmen

Schadendorf, Dirk

机构：

[1] Univ Duisburg Essen, Univ Hosp, Dept Dermatol, Essen, Germany

[2] Univ Tubingen, Dept Dermatol, Tubingen, Germany

[3] Elbekliniken, Dermatol Zentrum, Buxtehude, Germany

[4] Charite Campus Mitte, Univ Dept Dermatol, Berlin, Germany

[5] German Canc Res Ctr, Skin Canc Unit, Heidelberg, Germany

[6] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Dermatol Venereol & Allergol, Mannheim, Germany

[7] Univ Munich LMU, Dept Dermatol, Munich, Germany

[8] Univ Hosp, Dept Dermatol, Erlangen, Germany

[9] Univ Hosp Schleswig Holstein, Kiel, Germany

[10] Dept Dermatol, Ludwigshafen, Germany

[11] Dept Dermatol, Kassel, Germany

[12] Dept Dermatol, Munster, Germany

[13] Dept Dermatol, Minden, Germany

[14] Dept Dermatol, Erfurt, Germany

[15] Univ Hosp UKSH, Dept Dermatol, Lubeck, Germany

[16] Univ Tubingen Hosp, Dept Dermatol, Tubingen, Germany

[17] Univ Dept Dermatol, Mainz, Germany

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期

关键词：

D O I：

10.1200/jco.2014.32.15_suppl.9031

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

9031

引用

页数：1

共 50 条

[41] Efficacy and Safety of the Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma: Results from an Open-Label, Single-Arm, Multicenter Phase 3 Study [J].

Zager, Jonathan S. ;

Orloff, Marlana ;

Ferrucci, Pier Francesco ;

Choi, Junsung ;

Eschelman, David J. ;

Glazer, Evan S. ;

Ejaz, Aslam ;

Howard, J. Harrison ;

Richtig, Erika ;

Ochsenreither, Sebastian ;

Reddy, Sunil A. ;

Lowe, Michael C. ;

Beasley, Georgia M. ;

Gesierich, Anja ;

Bender, Armin ;

Gschnell, Martin ;

Dummer, Reinhard ;

Rivoire, Michel ;

Arance, Ana ;

Fenwick, Stephen William ;

Sacco, Joseph J. ;

Haferkamp, Sebastian ;

Weishaupt, Carsten ;

John, Johnny ;

Wheater, Matthew ;

Ottensmeier, Christian H. .

ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (08) :5340-5351

[42] Efficacy and Safety of Bavituximab in Combination with Sorafenib in Advanced Hepatocellular Carcinoma: A Single-Arm, Open-Label, Phase II Clinical Trial [J].

Ali A. Mokdad ;

Hao Zhu ;

Muhammad S. Beg ;

Yull Arriaga ;

Jonathan E. Dowell ;

Amit G. Singal ;

Adam C. Yopp .

Targeted Oncology, 2019, 14 :541-550

[43] Efficacy and Safety of Bavituximab in Combination with Sorafenib in Advanced Hepatocellular Carcinoma: A Single-Arm, Open-Label, Phase II Clinical Trial [J].

Mokdad, Ali A. ;

Zhu, Hao ;

Beg, Muhammad S. ;

Arriaga, Yull ;

Dowell, Jonathan E. ;

Singal, Amit G. ;

Yopp, Adam C. .

TARGETED ONCOLOGY, 2019, 14 (05) :541-550

[44] Efficacy and safety of endostatin in combination with chemotherapy in small cell lung cancer: a phase 2 single-arm multicenter open-label trial [J].

Zhao, Yi ;

Zhang, Xu ;

Jin, Chenxing ;

Yu, Xiaomin ;

Zhang, Min ;

Cao, Yang ;

Li, Ying ;

Wang, Aman ;

Shan, Xiu ;

Zhang, Jia ;

Wang, Juhong ;

Yin, Liu ;

Tan, Xiaoxin ;

Liu, Jiwei .

ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (03) :3277-3285

[45] Efficacy and safety of DCVAC/LuCa with chemotherapy for patients with stage IV NSCLC: A prospective, open-label, single-arm, phase II study [J].

Ling, X. ;

Xu, J. ;

Zhong, R. ;

Zhong, H. ;

Han, B. .

JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) :S752-S753

[46] A PROSPECTIVE, OPEN-LABEL, SINGLE-ARM STUDY TO EVALUATE EFFICACY, SAFETY AND ACCEPTABILITY OF PERICOITAL ORAL CONTRACEPTION WITH LEVONORGESTREL [J].

Lendvay, A. ;

Taylor, D. ;

Halpern, V ;

Bahamondes, L. ;

Fine, P. ;

Guide, S. ;

Raymond, E. .

CONTRACEPTION, 2012, 86 (03) :313-313

[47] TORIPALIMAB PLUS CHEMORADIOTHERAPY IN PATIENTS WITH RECURRENT OR METASTATIC CERVICAL CANCER: A MULTICENTER, OPEN-LABEL, SINGLE-ARM, PHASE II TRIAL [J].

Xu, Xiaoting ;

Huan, Jian ;

Miao, Hui ;

Wang, Hao ;

Wang, Yue ;

Zhu, Hongyu ;

Jiang, Jun ;

Zhou, Juying .

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 :A384-A384

[48] Camrelizumab Plus Apatinib in Patients With Advanced Cervical Cancer (CLAP): A Multicenter, Open-Label, Single-Arm, Phase II Trial [J].

Lan, Chunyan ;

Shen, Jingxian ;

Wang, Yin ;

Li, Jundong ;

Liu, Zhimin ;

He, Mian ;

Cao, Xinping ;

Ling, Jiayu ;

Huang, Jiaming ;

Zheng, Min ;

Zou, Guorong ;

Yan, Haowen ;

Liu, Qing ;

Yang, Fan ;

Wei, Wei ;

Deng, Yanhong ;

Xiong, Ying ;

Huang, Xin .

JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (34)

[49] Camrelizumab plus apatinib in patients with advanced cervical cancer: A multicenter, open-label, single-arm, phase II trial. [J].

Lan, Chunyan ;

Huang, Xin ;

Shen, Jing-Xian ;

Wang, Yin ;

Xiong, Ying ;

Li, Jundong ;

Cao, Xinping ;

Deng, Yanhong ;

He, Mian ;

Zou, Guorong ;

Wang, Xiaodi .

JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)

[50] Safety and Pharmacokinetics of Intravenous Zanamivir Treatment in Hospitalized Adults With Influenza: An Open-label, Multicenter, Single-Arm, Phase II Study [J].

Marty, Francisco M. ;

Man, Choy Y. ;

van der Horst, Charles ;

Francois, Bruno ;

Garot, Denis ;

Manez, Rafael ;

Thamlikitkul, Visanu ;

Lorente, Jose A. ;

Alvarez-Lerma, Francisco ;

Brealey, David ;

Zhao, Henry H. ;

Weller, Steve ;

Yates, Phillip J. ;

Peppercorn, Amanda F. .

JOURNAL OF INFECTIOUS DISEASES, 2014, 209 (04) :542-550

← 1 2 3 4 5 →